# Nuclide record opp-gpc3-hcc-china (opportunity). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/opportunities/opp-gpc3-hcc-china/>
  a schema:CreativeWork ;
  nuclide:kind "opportunity" ;
  schema:identifier "opp-gpc3-hcc-china" ;
  schema:name "GPC3 imaging of the indeterminate liver nodule, led from China"@en ;
  schema:alternateName "GPC3 PET"@en, "glypican-3 imaging"@en ;
  schema:description "Cirrhotic livers throw up nodules that scans cannot classify, and the usual answer is to wait three to six months to see if they grow. Several Chinese hospital programmes are testing tracers that recognise a protein carried by most liver cancers, and almost none of that work appears in Western pipeline reviews."@en ;
  schema:url <https://nuclide.cc/opportunities/opp-gpc3-hcc-china/> ;
  schema:dateModified "2026-09-23"^^xsd:date ;
  schema:citation <https://pubs.rsna.org/doi/full/10.1148/radiol.222801>, <https://pubmed.ncbi.nlm.nih.gov/39362766/>, <https://clinicaltrials.gov/study/NCT06383520>, <https://clinicaltrials.gov/study/NCT07352345>, <https://pubmed.ncbi.nlm.nih.gov/41688850/> ;
  nuclide:tag "non-US registry", "liver", "China", "indeterminate nodule" ;
  nuclide:related <https://nuclide.cc/isotopes/ga-68/> ;
  nuclide:indications <https://nuclide.cc/indications/hcc/> ;
  nuclide:technologies <https://nuclide.cc/technologies/immuno-pet/>, <https://nuclide.cc/technologies/pet-ct/>, <https://nuclide.cc/technologies/pet-mri/> ;
  nuclide:targets <https://nuclide.cc/targets/gpc3/> .